English
简体中文
Total: £ 56.28
Published Date: 2025-06-18 | Pages: 151 | Tables: 159 | Medical Care
In 2024, the global market size of Oligo Synthesis was estimated to be worth US$ 700 million and is forecast to reach approximately US$ 1492 million by 2031 with a CAGR of 11.6% during the forecast period 2025-2031.
Oligo synthesis, also known as oligonucleotide synthesis, is a laboratory technique used to chemically synthesize short sequences of nucleic acids, typically DNA or RNA oligonucleotides. These oligonucleotides are composed of relatively short chains of nucleotides, usually less than 100 bases in length. Oligos (or oligonucleotides) are commonly used as primers in PCR (polymerase chain reactions) to selectively amplify target DNA sequences. They can be tagged with fluorescent dyes or radioisotopes for detection purposes. Oligos are often used in DNA sequencing, gene synthesis, and genetic testing, and can be modified for gene therapies or gene expression.
Global key players of Oligo Synthesis include Thermo Fisher Scientific, Merck, Genscript, BBI Life Sciences, Integrated DNA Technologies (IDT), etc. The top five players hold a share about 44%. North America is the largest market, and has a share about 53%, followed by Asia-Pacific and Europe with share 25% and 15%, separately. In terms of product type, Common Primer Synthesis is the largest segment, occupied for a share of 64%. In terms of end user, Biotech Company has a share about 75 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oligo Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligo Synthesis.
The Oligo Synthesis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligo Synthesis market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligo Synthesis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Azenta Life Sciences
BBI Life Sciences
TriLink BioTechnologies
Aurigene Pharmaceutical Services
Integrated DNA Technologies (IDT)
Cusabio
Macrogen
Synbio Technologies
Eurogentec
Genscript
Abace Biotechnology
Tsingke
Guangzhou RiboBio
Atantares
Wuhan GeneCreate Biological Engineering
Beyotime
General Biol
Biosune
Segment by Type
Common Primer Synthesis
Modified Primer Synthesis
Segment by End User
Biotech Company
Academic Scientific Research Institution
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Oligo Synthesis in global and regional level.
Chapter 3: Detailed analysis of Oligo Synthesis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligo Synthesis revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by End User and by country, revenue for each segment.
Chapter 8: Europe by Type, by End User and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by End User and by region, revenue for each segment.
Chapter 10: Latin America by Type, by End User and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by End User and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Oligo Synthesis Product Introduction
1.2 Market by Type
1.2.1 Global Oligo Synthesis Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Common Primer Synthesis
1.2.3 Modified Primer Synthesis
1.3 Market by End User
1.3.1 Global Oligo Synthesis Market Size Growth Rate by End User (2020 VS 2024 VS 2031)
1.3.2 Biotech Company
1.3.3 Academic Scientific Research Institution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oligo Synthesis Market Size Estimates and Forecasts
2.2 Oligo Synthesis Market Size by Region: 2024 Versus 2031
2.2.1 Global Oligo Synthesis Revenue by Region: 2020-2025
2.2.2 Global Oligo Synthesis Revenue Forecast by Region (2026-2031)
2.2.3 Global Oligo Synthesis Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Oligo Synthesis Revenue by Type (2020-2031)
3.1.2 Global Oligo Synthesis Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by End User
3.2.1 Global Oligo Synthesis Revenue by End User (2020-2031)
3.2.2 Global Oligo Synthesis Revenue Market Share by End User (2020-2031)
3.3 by Type and by End User Crossing Analysis
3.3.1 Common Primer Synthesis of Oligo Synthesis Revenue Market Share by End User
3.3.2 Modified Primer Synthesis of Oligo Synthesis Revenue Market Share by End User
4 Global Oligo Synthesis by Company
4.1 Global Oligo Synthesis Revenue by Company (2020-2025)
4.2 Global Oligo Synthesis Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Oligo Synthesis Companies around the World: Ranking by Revenue
4.3.2 Global Oligo Synthesis Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Oligo Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Oligo Synthesis Companies Headquarters & Product Type
4.4.1 Global Oligo Synthesis Companies Headquarters
4.4.2 Date of International Companies Enter into Oligo Synthesis Market
4.4.3 Global Oligo Synthesis Companies Product & Service
4.4.4 Common Primer Synthesis Revenue Market Share of Oligo Synthesis by Company
4.4.5 Modified Primer Synthesis Revenue Market Share of Oligo Synthesis by Company
4.5 Global Oligo Synthesis Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Corporation Information
5.1.2 Thermo Fisher Scientific Description, Business Overview
5.1.3 Thermo Fisher Scientific Oligo Synthesis Products Offered
5.1.4 Thermo Fisher Scientific Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.1.5 Thermo Fisher Scientific Oligo Synthesis Revenue by Product in 2024
5.1.6 Thermo Fisher Scientific Oligo Synthesis Revenue by End User in 2024
5.1.7 Thermo Fisher Scientific Oligo Synthesis Revenue by Geographic Area in 2024
5.1.8 Thermo Fisher Scientific Recent Developments
5.2 Merck
5.2.1 Merck Corporation Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Oligo Synthesis Products Offered
5.2.4 Merck Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.2.5 Merck Oligo Synthesis Revenue by Product in 2024
5.2.6 Merck Oligo Synthesis Revenue by End User in 2024
5.2.7 Merck Oligo Synthesis Revenue by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 Azenta Life Sciences
5.3.1 Azenta Life Sciences Corporation Information
5.3.2 Azenta Life Sciences Description, Business Overview
5.3.3 Azenta Life Sciences Oligo Synthesis Products Offered
5.3.4 Azenta Life Sciences Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.3.5 Azenta Life Sciences Oligo Synthesis Revenue by Product in 2024
5.3.6 Azenta Life Sciences Oligo Synthesis Revenue by End User in 2024
5.3.7 Azenta Life Sciences Oligo Synthesis Revenue by Geographic Area in 2024
5.3.8 Azenta Life Sciences Recent Developments
5.4 BBI Life Sciences
5.4.1 BBI Life Sciences Corporation Information
5.4.2 BBI Life Sciences Description, Business Overview
5.4.3 BBI Life Sciences Oligo Synthesis Products Offered
5.4.4 BBI Life Sciences Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.4.5 BBI Life Sciences Oligo Synthesis Revenue by Product in 2024
5.4.6 BBI Life Sciences Oligo Synthesis Revenue by End User in 2024
5.4.7 BBI Life Sciences Oligo Synthesis Revenue by Geographic Area in 2024
5.4.8 BBI Life Sciences Recent Developments
5.5 TriLink BioTechnologies
5.5.1 TriLink BioTechnologies Corporation Information
5.5.2 TriLink BioTechnologies Description, Business Overview
5.5.3 TriLink BioTechnologies Oligo Synthesis Products Offered
5.5.4 TriLink BioTechnologies Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.5.5 TriLink BioTechnologies Oligo Synthesis Revenue by Product in 2024
5.5.6 TriLink BioTechnologies Oligo Synthesis Revenue by End User in 2024
5.5.7 TriLink BioTechnologies Oligo Synthesis Revenue by Geographic Area in 2024
5.5.8 TriLink BioTechnologies Recent Developments
5.6 Aurigene Pharmaceutical Services
5.6.1 Aurigene Pharmaceutical Services Corporation Information
5.6.2 Aurigene Pharmaceutical Services Description, Business Overview
5.6.3 Aurigene Pharmaceutical Services Oligo Synthesis Products Offered
5.6.4 Aurigene Pharmaceutical Services Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.6.5 Aurigene Pharmaceutical Services Oligo Synthesis Revenue by Product in 2024
5.6.6 Aurigene Pharmaceutical Services Oligo Synthesis Revenue by End User in 2024
5.6.7 Aurigene Pharmaceutical Services Oligo Synthesis Revenue by Geographic Area in 2024
5.6.8 Aurigene Pharmaceutical Services Recent Developments
5.7 Integrated DNA Technologies (IDT)
5.7.1 Integrated DNA Technologies (IDT) Corporation Information
5.7.2 Integrated DNA Technologies (IDT) Description, Business Overview
5.7.3 Integrated DNA Technologies (IDT) Oligo Synthesis Products Offered
5.7.4 Integrated DNA Technologies (IDT) Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.7.5 Integrated DNA Technologies (IDT) Oligo Synthesis Revenue by Product in 2024
5.7.6 Integrated DNA Technologies (IDT) Oligo Synthesis Revenue by End User in 2024
5.7.7 Integrated DNA Technologies (IDT) Oligo Synthesis Revenue by Geographic Area in 2024
5.7.8 Integrated DNA Technologies (IDT) Recent Developments
5.8 Cusabio
5.8.1 Cusabio Corporation Information
5.8.2 Cusabio Description, Business Overview
5.8.3 Cusabio Oligo Synthesis Products Offered
5.8.4 Cusabio Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.8.5 Cusabio Oligo Synthesis Revenue by Product in 2024
5.8.6 Cusabio Oligo Synthesis Revenue by End User in 2024
5.8.7 Cusabio Oligo Synthesis Revenue by Geographic Area in 2024
5.8.8 Cusabio Recent Developments
5.9 Macrogen
5.9.1 Macrogen Corporation Information
5.9.2 Macrogen Description, Business Overview
5.9.3 Macrogen Oligo Synthesis Products Offered
5.9.4 Macrogen Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.9.5 Macrogen Oligo Synthesis Revenue by Product in 2024
5.9.6 Macrogen Oligo Synthesis Revenue by End User in 2024
5.9.7 Macrogen Oligo Synthesis Revenue by Geographic Area in 2024
5.9.8 Macrogen Recent Developments
5.10 Synbio Technologies
5.10.1 Synbio Technologies Corporation Information
5.10.2 Synbio Technologies Description, Business Overview
5.10.3 Synbio Technologies Oligo Synthesis Products Offered
5.10.4 Synbio Technologies Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.10.5 Synbio Technologies Oligo Synthesis Revenue by Product in 2024
5.10.6 Synbio Technologies Oligo Synthesis Revenue by End User in 2024
5.10.7 Synbio Technologies Oligo Synthesis Revenue by Geographic Area in 2024
5.10.8 Synbio Technologies Recent Developments
5.11 Eurogentec
5.11.1 Eurogentec Corporation Information
5.11.2 Eurogentec Description, Business Overview
5.11.3 Eurogentec Oligo Synthesis Products Offered
5.11.4 Eurogentec Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.11.5 Eurogentec Oligo Synthesis Revenue by Product in 2024
5.11.6 Eurogentec Oligo Synthesis Revenue by End User in 2024
5.11.7 Eurogentec Oligo Synthesis Revenue by Geographic Area in 2024
5.11.8 Eurogentec Recent Developments
5.12 Genscript
5.12.1 Genscript Corporation Information
5.12.2 Genscript Description, Business Overview
5.12.3 Genscript Oligo Synthesis Products Offered
5.12.4 Genscript Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.12.5 Genscript Oligo Synthesis Revenue by Product in 2024
5.12.6 Genscript Oligo Synthesis Revenue by End User in 2024
5.12.7 Genscript Oligo Synthesis Revenue by Geographic Area in 2024
5.12.8 Genscript Recent Developments
5.13 Abace Biotechnology
5.13.1 Abace Biotechnology Corporation Information
5.13.2 Abace Biotechnology Description, Business Overview
5.13.3 Abace Biotechnology Oligo Synthesis Products Offered
5.13.4 Abace Biotechnology Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.13.5 Abace Biotechnology Oligo Synthesis Revenue by Product in 2024
5.13.6 Abace Biotechnology Oligo Synthesis Revenue by End User in 2024
5.13.7 Abace Biotechnology Oligo Synthesis Revenue by Geographic Area in 2024
5.13.8 Abace Biotechnology Recent Developments
5.14 Tsingke
5.14.1 Tsingke Corporation Information
5.14.2 Tsingke Description, Business Overview
5.14.3 Tsingke Oligo Synthesis Products Offered
5.14.4 Tsingke Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.14.5 Tsingke Oligo Synthesis Revenue by Product in 2024
5.14.6 Tsingke Oligo Synthesis Revenue by End User in 2024
5.14.7 Tsingke Oligo Synthesis Revenue by Geographic Area in 2024
5.14.8 Tsingke Recent Developments
5.15 Guangzhou RiboBio
5.15.1 Guangzhou RiboBio Corporation Information
5.15.2 Guangzhou RiboBio Description, Business Overview
5.15.3 Guangzhou RiboBio Oligo Synthesis Products Offered
5.15.4 Guangzhou RiboBio Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.15.5 Guangzhou RiboBio Oligo Synthesis Revenue by Product in 2024
5.15.6 Guangzhou RiboBio Oligo Synthesis Revenue by End User in 2024
5.15.7 Guangzhou RiboBio Oligo Synthesis Revenue by Geographic Area in 2024
5.15.8 Guangzhou RiboBio Recent Developments
5.16 Atantares
5.16.1 Atantares Corporation Information
5.16.2 Atantares Description, Business Overview
5.16.3 Atantares Oligo Synthesis Products Offered
5.16.4 Atantares Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.16.5 Atantares Oligo Synthesis Revenue by Product in 2024
5.16.6 Atantares Oligo Synthesis Revenue by End User in 2024
5.16.7 Atantares Oligo Synthesis Revenue by Geographic Area in 2024
5.16.8 Atantares Recent Developments
5.17 Wuhan GeneCreate Biological Engineering
5.17.1 Wuhan GeneCreate Biological Engineering Corporation Information
5.17.2 Wuhan GeneCreate Biological Engineering Description, Business Overview
5.17.3 Wuhan GeneCreate Biological Engineering Oligo Synthesis Products Offered
5.17.4 Wuhan GeneCreate Biological Engineering Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.17.5 Wuhan GeneCreate Biological Engineering Oligo Synthesis Revenue by Product in 2024
5.17.6 Wuhan GeneCreate Biological Engineering Oligo Synthesis Revenue by End User in 2024
5.17.7 Wuhan GeneCreate Biological Engineering Oligo Synthesis Revenue by Geographic Area in 2024
5.17.8 Wuhan GeneCreate Biological Engineering Recent Developments
5.18 Beyotime
5.18.1 Beyotime Corporation Information
5.18.2 Beyotime Description, Business Overview
5.18.3 Beyotime Oligo Synthesis Products Offered
5.18.4 Beyotime Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.18.5 Beyotime Oligo Synthesis Revenue by Product in 2024
5.18.6 Beyotime Oligo Synthesis Revenue by End User in 2024
5.18.7 Beyotime Oligo Synthesis Revenue by Geographic Area in 2024
5.18.8 Beyotime Recent Developments
5.19 General Biol
5.19.1 General Biol Corporation Information
5.19.2 General Biol Description, Business Overview
5.19.3 General Biol Oligo Synthesis Products Offered
5.19.4 General Biol Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.19.5 General Biol Oligo Synthesis Revenue by Product in 2024
5.19.6 General Biol Oligo Synthesis Revenue by End User in 2024
5.19.7 General Biol Oligo Synthesis Revenue by Geographic Area in 2024
5.19.8 General Biol Recent Developments
5.20 Biosune
5.20.1 Biosune Corporation Information
5.20.2 Biosune Description, Business Overview
5.20.3 Biosune Oligo Synthesis Products Offered
5.20.4 Biosune Oligo Synthesis Revenue and Gross Margin (2020-2025)
5.20.5 Biosune Oligo Synthesis Revenue by Product in 2024
5.20.6 Biosune Oligo Synthesis Revenue by End User in 2024
5.20.7 Biosune Oligo Synthesis Revenue by Geographic Area in 2024
5.20.8 Biosune Recent Developments
6 North America
6.1 North America Oligo Synthesis Market Size YoY Growth 2020-2031
6.2 North America Oligo Synthesis Market Facts & Figures by Country (2020-2031)
6.3 North America Oligo Synthesis Revenue by Type (2020-2025)
6.4 North America Oligo Synthesis Revenue by End User (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Oligo Synthesis Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Oligo Synthesis Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Oligo Synthesis Revenue by Type (2020-2025)
7.4 Asia-Pacific Oligo Synthesis Revenue by End User (2020-2025)
8 Europe
8.1 Europe Oligo Synthesis Market Size YoY Growth 2020-2031
8.2 Europe Oligo Synthesis Market Facts & Figures by Country (2020-2031)
8.3 Europe Oligo Synthesis Revenue by Type (2020-2025)
8.4 Europe Oligo Synthesis Revenue by End User (2020-2025)
9 Latin America
9.1 Latin America Oligo Synthesis Market Size YoY Growth 2020-2031
9.2 Latin America Oligo Synthesis Market Facts & Figures by Country (2020-2031)
9.3 Latin America Oligo Synthesis Revenue by Type (2020-2025)
9.4 Latin America Oligo Synthesis Revenue by End User (2020-2025)
10 Middle East and Africa
10.1 Latin America Oligo Synthesis Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Oligo Synthesis Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Oligo Synthesis Revenue by Type (2020-2025)
10.4 Middle East and Africa Oligo Synthesis Revenue by End User (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Oligo Synthesis Supply Chain Analysis
11.2 Oligo Synthesis Key Raw Materials and Upstream Suppliers
11.3 Oligo Synthesis Clients Analysis
11.4 Oligo Synthesis Sales Channel and Sales Model Analysis
11.4.1 Oligo Synthesis Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Oligo Synthesis Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Oligo Synthesis Distributors
12 Oligo Synthesis Market Dynamics
12.1 Oligo Synthesis Industry Trends
12.2 Oligo Synthesis Market Drivers
12.3 Oligo Synthesis Market Challenges
12.4 Oligo Synthesis Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Oligo Synthesis Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Oligo Synthesis Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Oligo Synthesis Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Oligo Synthesis Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Oligo Synthesis Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Oligo Synthesis Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Oligo Synthesis Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Oligo Synthesis Revenue by End User (2020-2025) & (US$ Million)
Table 9. Global Oligo Synthesis Revenue Forecast by End User (2026-2031) & (US$ Million)
Table 10. Oligo Synthesis Revenue by Company (2020-2025) & (US$ Million)
Table 11. Oligo Synthesis Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Oligo Synthesis Players by Revenue (US$ Million) in 2024
Table 13. Global Oligo Synthesis Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Oligo Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligo Synthesis as of 2024)
Table 15. Global Oligo Synthesis Companies Headquarters
Table 16. Date of International Companies Enter into Oligo Synthesis Market
Table 17. Global Oligo Synthesis Companies Product & Service
Table 18. Global Oligo Synthesis Mergers & Acquisitions, Expansion Plans
Table 19. Thermo Fisher Scientific Corporation Information
Table 20. Thermo Fisher Scientific Description and Business Overview
Table 21. Thermo Fisher Scientific Oligo Synthesis Product
Table 22. Thermo Fisher Scientific Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Thermo Fisher Scientific Revenue Proportion of Oligo Synthesis by Product in 2024
Table 24. Thermo Fisher Scientific Revenue Proportion of Oligo Synthesis by End User in 2024
Table 25. Thermo Fisher Scientific Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. Merck Corporation Information
Table 28. Merck Description and Business Overview
Table 29. Merck Oligo Synthesis Product
Table 30. Merck Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Merck Revenue Proportion of Oligo Synthesis by Product in 2024
Table 32. Merck Revenue Proportion of Oligo Synthesis by End User in 2024
Table 33. Merck Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 34. Merck Recent Developments
Table 35. Azenta Life Sciences Corporation Information
Table 36. Azenta Life Sciences Description and Business Overview
Table 37. Azenta Life Sciences Oligo Synthesis Product
Table 38. Azenta Life Sciences Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Azenta Life Sciences Revenue Proportion of Oligo Synthesis by Product in 2024
Table 40. Azenta Life Sciences Revenue Proportion of Oligo Synthesis by End User in 2024
Table 41. Azenta Life Sciences Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 42. Azenta Life Sciences Recent Developments
Table 43. BBI Life Sciences Corporation Information
Table 44. BBI Life Sciences Description and Business Overview
Table 45. BBI Life Sciences Oligo Synthesis Product
Table 46. BBI Life Sciences Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. BBI Life Sciences Revenue Proportion of Oligo Synthesis by Product in 2024
Table 48. BBI Life Sciences Revenue Proportion of Oligo Synthesis by End User in 2024
Table 49. BBI Life Sciences Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 50. BBI Life Sciences Recent Developments
Table 51. TriLink BioTechnologies Corporation Information
Table 52. TriLink BioTechnologies Description and Business Overview
Table 53. TriLink BioTechnologies Oligo Synthesis Product
Table 54. TriLink BioTechnologies Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. TriLink BioTechnologies Revenue Proportion of Oligo Synthesis by Product in 2024
Table 56. TriLink BioTechnologies Revenue Proportion of Oligo Synthesis by End User in 2024
Table 57. TriLink BioTechnologies Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 58. TriLink BioTechnologies Recent Developments
Table 59. Aurigene Pharmaceutical Services Corporation Information
Table 60. Aurigene Pharmaceutical Services Description and Business Overview
Table 61. Aurigene Pharmaceutical Services Oligo Synthesis Product
Table 62. Aurigene Pharmaceutical Services Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Aurigene Pharmaceutical Services Revenue Proportion of Oligo Synthesis by Product in 2024
Table 64. Aurigene Pharmaceutical Services Revenue Proportion of Oligo Synthesis by End User in 2024
Table 65. Aurigene Pharmaceutical Services Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 66. Aurigene Pharmaceutical Services Recent Developments
Table 67. Integrated DNA Technologies (IDT) Corporation Information
Table 68. Integrated DNA Technologies (IDT) Description and Business Overview
Table 69. Integrated DNA Technologies (IDT) Oligo Synthesis Product
Table 70. Integrated DNA Technologies (IDT) Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Integrated DNA Technologies (IDT) Revenue Proportion of Oligo Synthesis by Product in 2024
Table 72. Integrated DNA Technologies (IDT) Revenue Proportion of Oligo Synthesis by End User in 2024
Table 73. Integrated DNA Technologies (IDT) Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 74. Integrated DNA Technologies (IDT) Recent Developments
Table 75. Cusabio Corporation Information
Table 76. Cusabio Description and Business Overview
Table 77. Cusabio Oligo Synthesis Product
Table 78. Cusabio Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Cusabio Revenue Proportion of Oligo Synthesis by Product in 2024
Table 80. Cusabio Revenue Proportion of Oligo Synthesis by End User in 2024
Table 81. Cusabio Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 82. Cusabio Recent Developments
Table 83. Macrogen Corporation Information
Table 84. Macrogen Description and Business Overview
Table 85. Macrogen Oligo Synthesis Product
Table 86. Macrogen Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Macrogen Revenue Proportion of Oligo Synthesis by Product in 2024
Table 88. Macrogen Revenue Proportion of Oligo Synthesis by End User in 2024
Table 89. Macrogen Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 90. Macrogen Recent Developments
Table 91. Synbio Technologies Corporation Information
Table 92. Synbio Technologies Description and Business Overview
Table 93. Synbio Technologies Oligo Synthesis Product
Table 94. Synbio Technologies Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Synbio Technologies Revenue Proportion of Oligo Synthesis by Product in 2024
Table 96. Synbio Technologies Revenue Proportion of Oligo Synthesis by End User in 2024
Table 97. Synbio Technologies Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 98. Synbio Technologies Recent Developments
Table 99. Eurogentec Corporation Information
Table 100. Eurogentec Description and Business Overview
Table 101. Eurogentec Oligo Synthesis Product
Table 102. Eurogentec Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Eurogentec Revenue Proportion of Oligo Synthesis by Product in 2024
Table 104. Eurogentec Revenue Proportion of Oligo Synthesis by End User in 2024
Table 105. Eurogentec Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 106. Eurogentec Recent Developments
Table 107. Genscript Corporation Information
Table 108. Genscript Description and Business Overview
Table 109. Genscript Oligo Synthesis Product
Table 110. Genscript Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Genscript Revenue Proportion of Oligo Synthesis by Product in 2024
Table 112. Genscript Revenue Proportion of Oligo Synthesis by End User in 2024
Table 113. Genscript Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 114. Genscript Recent Developments
Table 115. Abace Biotechnology Corporation Information
Table 116. Abace Biotechnology Description and Business Overview
Table 117. Abace Biotechnology Oligo Synthesis Product
Table 118. Abace Biotechnology Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Abace Biotechnology Revenue Proportion of Oligo Synthesis by Product in 2024
Table 120. Abace Biotechnology Revenue Proportion of Oligo Synthesis by End User in 2024
Table 121. Abace Biotechnology Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 122. Abace Biotechnology Recent Developments
Table 123. Tsingke Corporation Information
Table 124. Tsingke Description and Business Overview
Table 125. Tsingke Oligo Synthesis Product
Table 126. Tsingke Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Tsingke Revenue Proportion of Oligo Synthesis by Product in 2024
Table 128. Tsingke Revenue Proportion of Oligo Synthesis by End User in 2024
Table 129. Tsingke Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 130. Tsingke Recent Developments
Table 131. Guangzhou RiboBio Corporation Information
Table 132. Guangzhou RiboBio Description and Business Overview
Table 133. Guangzhou RiboBio Oligo Synthesis Product
Table 134. Guangzhou RiboBio Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Guangzhou RiboBio Revenue Proportion of Oligo Synthesis by Product in 2024
Table 136. Guangzhou RiboBio Revenue Proportion of Oligo Synthesis by End User in 2024
Table 137. Guangzhou RiboBio Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 138. Guangzhou RiboBio Recent Developments
Table 139. Atantares Corporation Information
Table 140. Atantares Description and Business Overview
Table 141. Atantares Oligo Synthesis Product
Table 142. Atantares Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Atantares Revenue Proportion of Oligo Synthesis by Product in 2024
Table 144. Atantares Revenue Proportion of Oligo Synthesis by End User in 2024
Table 145. Atantares Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 146. Atantares Recent Developments
Table 147. Wuhan GeneCreate Biological Engineering Corporation Information
Table 148. Wuhan GeneCreate Biological Engineering Description and Business Overview
Table 149. Wuhan GeneCreate Biological Engineering Oligo Synthesis Product
Table 150. Wuhan GeneCreate Biological Engineering Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Wuhan GeneCreate Biological Engineering Revenue Proportion of Oligo Synthesis by Product in 2024
Table 152. Wuhan GeneCreate Biological Engineering Revenue Proportion of Oligo Synthesis by End User in 2024
Table 153. Wuhan GeneCreate Biological Engineering Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 154. Wuhan GeneCreate Biological Engineering Recent Developments
Table 155. Beyotime Corporation Information
Table 156. Beyotime Description and Business Overview
Table 157. Beyotime Oligo Synthesis Product
Table 158. Beyotime Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Beyotime Revenue Proportion of Oligo Synthesis by Product in 2024
Table 160. Beyotime Revenue Proportion of Oligo Synthesis by End User in 2024
Table 161. Beyotime Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 162. Beyotime Recent Developments
Table 163. General Biol Corporation Information
Table 164. General Biol Description and Business Overview
Table 165. General Biol Oligo Synthesis Product
Table 166. General Biol Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. General Biol Revenue Proportion of Oligo Synthesis by Product in 2024
Table 168. General Biol Revenue Proportion of Oligo Synthesis by End User in 2024
Table 169. General Biol Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 170. General Biol Recent Developments
Table 171. Biosune Corporation Information
Table 172. Biosune Description and Business Overview
Table 173. Biosune Oligo Synthesis Product
Table 174. Biosune Oligo Synthesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 175. Biosune Revenue Proportion of Oligo Synthesis by Product in 2024
Table 176. Biosune Revenue Proportion of Oligo Synthesis by End User in 2024
Table 177. Biosune Revenue Proportion of Oligo Synthesis by Geographic Area in 2024
Table 178. Biosune Recent Developments
Table 179. North America Oligo Synthesis Revenue by Country (2020-2025) & (US$ Million)
Table 180. North America Oligo Synthesis Revenue by Country (2026-2031) & (US$ Million)
Table 181. North America Oligo Synthesis Revenue by Type (2020-2025) & (US$ Million)
Table 182. North America Oligo Synthesis Revenue by End User (2020-2025) & (US$ Million)
Table 183. Asia-Pacific Oligo Synthesis Revenue by Region (2020-2025) & (US$ Million)
Table 184. Asia-Pacific Oligo Synthesis Revenue by Region (2026-2031) & (US$ Million)
Table 185. Asia-Pacific Oligo Synthesis Revenue by Type (2020-2025) & (US$ Million)
Table 186. Asia-Pacific Oligo Synthesis Revenue by End User (2020-2025) & (US$ Million)
Table 187. Europe Oligo Synthesis Revenue by Country (2020-2025) & (US$ Million)
Table 188. Europe Oligo Synthesis Revenue by Country (2026-2031) & (US$ Million)
Table 189. Europe Oligo Synthesis Revenue by Type (2020-2025) & (US$ Million)
Table 190. Europe Oligo Synthesis Revenue by End User (2020-2025) & (US$ Million)
Table 191. Latin America Oligo Synthesis Revenue by Country (2020-2025) & (US$ Million)
Table 192. Latin America Oligo Synthesis Revenue by Country (2026-2031) & (US$ Million)
Table 193. Latin America Oligo Synthesis Revenue by Type (2020-2025) & (US$ Million)
Table 194. Latin America Oligo Synthesis Revenue by End User (2020-2025) & (US$ Million)
Table 195. Middle East and Africa Oligo Synthesis Revenue by Country (2020-2025) & (US$ Million)
Table 196. Middle East and Africa Oligo Synthesis Revenue by Country (2026-2031) & (US$ Million)
Table 197. Middle East and Africa Oligo Synthesis Revenue by Type (2020-2025) & (US$ Million)
Table 198. Middle East and Africa Oligo Synthesis Revenue by End User (2020-2025) & (US$ Million)
Table 199. Oligo Synthesis Key Raw Materials, Industry Status and Trend
Table 200. Oligo Synthesis Key Raw Materials and Upstream Suppliers
Table 201. Oligo Synthesis Clients Status and Trend
Table 202. Oligo Synthesis Typical Clients
Table 203. Oligo Synthesis Distributors
Table 204. Oligo Synthesis Market Trends
Table 205. Oligo Synthesis Market Drivers
Table 206. Oligo Synthesis Market Challenges
Table 207. Oligo Synthesis Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Oligo Synthesis Product Picture
Figure 2. Global Oligo Synthesis Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Oligo Synthesis Revenue Market Share by Type in 2024 & 2031
Figure 4. Common Primer Synthesis Product Picture
Figure 5. Modified Primer Synthesis Product Picture
Figure 6. Global Oligo Synthesis Market Size by End User (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Oligo Synthesis Revenue Market Share by End User in 2024 & 2031
Figure 8. Biotech Company
Figure 9. Academic Scientific Research Institution
Figure 10. Oligo Synthesis Report Years Considered
Figure 11. Global Oligo Synthesis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Oligo Synthesis Market Size (2020-2031) & (US$ Million)
Figure 13. Global Oligo Synthesis Market Size Market Share by Region: 2024 Versus 2031
Figure 14. Global Oligo Synthesis Revenue Market Share by Region (2020-2031)
Figure 15. Global Oligo Synthesis Revenue Market Share Forecast by Type (2020-2031)
Figure 16. Global Oligo Synthesis Revenue Market Share Forecast by End User (2020-2031)
Figure 17. Common Primer Synthesis of Oligo Synthesis Revenue Market Share by End User, 2024 VS 2031
Figure 18. Modified Primer Synthesis of Oligo Synthesis Revenue Market Share by End User, 2024 VS 2031
Figure 19. Oligo Synthesis Revenue Share by Company (2024)
Figure 20. Oligo Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Common Primer Synthesis Revenue Proportion by Company in 2024
Figure 22. Modified Primer Synthesis Revenue Proportion by Company in 2024
Figure 23. North America Oligo Synthesis Revenue 2020-2031 (US$ Million)
Figure 24. North America Oligo Synthesis Revenue Market Share by Type (2020-2025)
Figure 25. North America Oligo Synthesis Revenue Market Share by End User (2020-2025)
Figure 26. Asia-Pacific Oligo Synthesis Revenue 2020-2031 (US$ Million)
Figure 27. Asia-Pacific Oligo Synthesis Revenue Market Share by Region (2020-2031)
Figure 28. Asia-Pacific Oligo Synthesis Revenue Market Share by Type (2020-2025)
Figure 29. Asia-Pacific Oligo Synthesis Revenue Market Share by End User (2020-2025)
Figure 30. Europe Oligo Synthesis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 31. Europe Oligo Synthesis Revenue Market Share by Country (2020-2031)
Figure 32. Europe Oligo Synthesis Revenue Market Share by Type (2020-2025)
Figure 33. Europe Oligo Synthesis Revenue Market Share by End User (2020-2025)
Figure 34. Latin America Oligo Synthesis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Latin America Oligo Synthesis Revenue Market Share by Country (2020-2031)
Figure 36. Latin America Oligo Synthesis Revenue Market Share by Type (2020-2025)
Figure 37. Latin America Oligo Synthesis Revenue Market Share by End User (2020-2025)
Figure 38. Middle East and Africa Oligo Synthesis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Middle East and Africa Oligo Synthesis Revenue Market Share by Country (2020-2031)
Figure 40. Middle East and Africa Oligo Synthesis Revenue Market Share by Type (2020-2025)
Figure 41. Middle East and Africa Oligo Synthesis Revenue Market Share by End User (2020-2025)
Figure 42. Oligo Synthesis Supply Chain (Upstream and Downstream Market)
Figure 43. Global Production Market Share of Oligo Synthesis Raw Materials by Region in 2024
Figure 44. Oligo Synthesis Distribution Channels
Figure 45. Global Oligo Synthesis Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 46. Global Oligo Synthesis Percentage 2020-2031: Online Sales VS Offline Sales
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
